Host factors involved in low susceptibility to HIV infection

AIDS Reviews

Volumn 13, Issue 1, 2011, Pages 30-40

  Restrepo, Clara ^a   Ralloń, Norma I ^a   Carrillo, Jorge ^b   Soriano, Vincent ^a   Blanco, Julia ^b   Benito, José M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b IrsiCaixa Foundation   (Spain)

Author keywords

ESN; Genetic factors; HIV; Immune response; Resistance

Indexed keywords

ALPHA DEFENSIN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; AUTOANTIBODY; BETA CHEMOKINE; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD209 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; DEFENSIN; ELAFIN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; HOST FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 2; INTERLEUKIN 22; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PEROXIREDOXIN 2; RANTES; TRIPARTITE MOTIF PROTEIN 5; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; AFRICAN AMERICAN; ALLELE; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; BREAST FEEDING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CELLULAR IMMUNITY; CHILDBIRTH; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; DNA POLYMORPHISM; GENE INTERACTION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HETEROSEXUALITY; HLA SYSTEM; HOMOZYGOSITY; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOMODULATION; INFECTION SENSITIVITY; INNATE IMMUNITY; INTRAVENOUS DRUG ABUSE; LYSIS; MACROPHAGE; MALE HOMOSEXUAL; MAST CELL; MUCOSAL IMMUNITY; NATURAL KILLER CELL; ORAL SEXUAL CONTACT; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSTITUTION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEOMICS; RISK FACTOR; SEROCONVERSION; SEXUAL TRANSMISSION; SEXUALITY; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; VAGINA MUCOSA; VERTICAL TRANSMISSION; VIREMIA; VIRUS ENTRY; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; PATHOGENICITY; REVIEW; VIROLOGY;

HIV; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE;

EID: 79960650778     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (111)

1. Rowland-Jones S., McMichael A. Immune responses in HIV-exposed seronegatives:Have they repelled the virus? Curr Opin Immunol. 1995;7:448-455
2. Jennes W., Vuylsteke B., Borget M., et al. HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire. J Infect Dis. 2004;189:602-610 (Pubitemid 38270912)
3. Hladik F., Desbien A., Lang J., et al. Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells. J Immunol. 2003;171:2671-2683 (Pubitemid 37025581)
4. Makedonas G., Bruneau J., Lin H., Sekaly R., Lamothe F., Bernard N.F. HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity. AIDS. 2002;16:1595-1602 (Pubitemid 34921104)
5. Salkowitz J., Purvis S., Meyerson H., et al. Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol. 2001;98:200-211
6. Clerici M., Levin J., Kessler H., et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA. 1994;271:42-46 (Pubitemid 24020578)
7. Hygino J., Lima P., Filho R., et al. Altered immunological reactivity in HIV-1-exposed uninfected neonates. Clin Immunol. 2008;127:340-347
8. Lo Caputo S., Trabattoni D., Vichi F., et al. Mucosal and systemic HIV-1- specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS. 2003;17:531-539 (Pubitemid 36293106)
9. Promadej N., Costello C., Wernett M., et al. Broad HIV-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner. J Infect Dis. 2003;187:1053-1063 (Pubitemid 36399347)
10. Suy A., Castro P., Nomdedeu M., et al. Immunological profile of heterosexual highly HIV-exposed uninfected individuals:Predominant role of CD4 and CD8 T-cell activation. J Infect Dis. 2007;196:1191-1201 (Pubitemid 47580274)
11. Miyazawa M., Lopalco L., Mazzotta F., et al. The 'immunologic advantage'of HIV-exposed seronegative individuals. AIDS. 2009;23:161-175
12. Goulder P., Watkins D. Impact of MHC class I diversity on immune control of HIV replication. Nat Rev Immunol. 2008;8:619-630
13. Carrington M., O'Brien S. The influence of HLA genotype on AIDS. Annu Rev Med. 2003;54:535-551 (Pubitemid 37386411)
14. Mackelprang R., John-Stewart G., Carrington M., et al. Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. J Infect Dis. 2008;197:1156-1161 (Pubitemid 351590051)
15. MacDonald K., Embree J., Njenga S. et al. Mother-child class I HLA concordance increases perinatal HIV type 1 transmission. J Infect Dis. 1998;177:551-556 (Pubitemid 28099866)
16. Flores-Villanueva P., Yunis E., Delgado J., et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci USA. 2001;98:5140-5145 (Pubitemid 32397096)
17. MacDonald K., Embree J., Nagelkerke N., et al. The HLA A2/6802 supertype is associated with reduced risk of perinatal HIV type 1 transmission. J Infect Dis. 2001;183:503-506 (Pubitemid 32105610)
18. MacDonald K., Fowke K., Kimani J., et al. Influence of HLA supertypes on susceptibility and resistance to HIV type 1 infection. J Infect Dis. 2000;181:1581-1589 (Pubitemid 30387748)
19. Welzel T., Gao X., Pfeiffer R., et al. HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples. AIDS. 2007;21:225-229 (Pubitemid 46036931)
20. Tang J., Shao W., Yoo Y., et al. Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples. J Immunol. 2008;181:2626-2635
21. Gao X., O'Brien T., Welzel T., et al. HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS. 2010;24:1835-1840
22. Lajoie J., Hargrove J., Zijenah L., Humphrey J., Ward B., Roger M. Genetic variants in non-classical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J Infect Dis. 2006;193:298-301. (Pubitemid 43113493)
23. Hardie R., Knight E., Bruneau B., et al. A common human leucocyte antigen- DP genotype is associated with resistance to HIV-1 infection in Kenyan sex workers. AIDS. 2008;22:2038-2042
24. Hardie R., Luo M., Bruneau B., et al. Human leukocyte antigen-DQ alleles and haplotypes and their associations with resistance and susceptibility to HIV-1 infection. AIDS. 2008;22:807-816 (Pubitemid 351563829)
25. Jennes W., Verheyden S., Demanet C., et al. Cutting edge:Resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol. 2006;177:6588-6592 (Pubitemid 44715020)
26. Ravet S., Scott-Algara D., Bonnet E., et al. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood. 2007;109:4296-4305 (Pubitemid 46743396)
27. Boulet S., Sharafi S., Simic N., et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS. 2008; 22:595-599 (Pubitemid 351640592)
28. Boulet S., Kleyman M., Kim J., et al. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS. 2008;22:1487-1491
29. Liu R., Paxton W., Choe S., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367-377 (Pubitemid 26272077)
30. Buseyne F., Janvier G., Teglas J., et al. Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally HIV-infected children at 8 years of age. J Infect Dis. 1998;178:1019-1023 (Pubitemid 28452193)
31. Hladik F., Liu H., Speelmon E., et al. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to HIV type 1 transmission. J Virol. 2005;79:11677-11684 (Pubitemid 41279286)
32. Louisirirotchanakul S., Liu H., Roongpisuthipong A., et al. Genetic analysis of HIV-1 discordant couples in Thailand:Association of CCR2 64I homozygosity with HIV-1-negative status. J Acquir Immune Defic Syndr. 2002;29:314-315 (Pubitemid 34208542)
33. Modi W., Lautenberger J., An P., et al. Genetic variation in the CCL18- CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression. Am J Hum Genet. 2006;79:120-128 (Pubitemid 43927382)
34. McDermott D., Beecroft M., Kleeberger C., et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS. 2000;14: 2671-2678 (Pubitemid 32118720)
35. Gonzalez E., Kulkarni H., Bolivar H., et al. The influence of CCL3L1 genecontaining segmental duplications on HIV-1/AIDS susceptibility. Science. 2005;307:1434-1440 (Pubitemid 40321934)
36. Kuhn L., Schramm D., Donninger S., et al. African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS. 2007;21:1753-1761 (Pubitemid 47237563)
37. Urban T., Weintrob A., Fellay J., et al. CCL3L1 and HIV/AIDS susceptibility. Nat Med. 2009;15:1110-1112
38. Lehner T., Wang Y., Pido-Lopez J., Whittall T., Bergmeier L., Babaahmady K. The emerging role of innate immunity in protection against HIV-1 infection. Vaccine. 2008;26:2997-3001.
39. Scott-Algara D., Truong L., Versmisse P., et al. Cutting edge:Increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol. 2003;171:5663-5667 (Pubitemid 37467178)
40. Montoya C., Velilla P., Chougnet C., Landay A.L., Rugeles M. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol. 2006;120: 138-146 (Pubitemid 44080673)
41. Tiemessen C., Shalekoff S., Meddows-Taylor S., et al. Cutting Edge:Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1. J Immunol. 2009; 182:5914-5918
42. Trabattoni D., Caputo S., Maffeis G., et al. Human alpha defensin in HIV-exposed but uninfected individuals. J Acquir Immune Defic Syndr. 2004;35:455-463 (Pubitemid 38420654)
43. Levinson P., Kaul R., Kimani J., et al. Levels of innate immune factors in genital fluids:Association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS. 2009;23:309-317
44. Zapata W., Rodriguez B., Weber J., et al. Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr HIV Res. 2008;6:531-538
45. Ricci E., Malacrida S., Zanchetta M., Montagna M., Giaquinto C., De Rossi A. Role of beta-defensin-1 polymorphisms in mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr. 2009;51:13-19.
46. Misse D., Yssel H., Trabattoni D., et al. IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J Immunol. 2007;178:407-415 (Pubitemid 46033624)
47. Hasselrot K., Bratt G., Duvefelt K., Hirbod T., Sandstrom E., Broliden K. HIV-1 exposed uninfected men who have sex with men have increased levels of salivary CC-chemokines associated with sexual behavior. AIDS. 2010;24:1569-1575
48. Iqbal S., Ball T., Kimani J., et al. Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. J Infect Dis. 2005;192:728-738 (Pubitemid 41193070)
49. Kaul R., Rebbapragada A., Hirbod T., et al. Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility. AIDS. 2008;22:2049-2051
50. Iqbal S., Ball T., Levinson P., et al. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS. 2009;23:1669-1677
51. Rathore A., Chatterjee A., Sivarama P., Yamamoto N., Dhole T. Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indian individuals. J Clin Immunol. 2008; 28:50-57
52. Wichukchinda N., Kitamura Y., Rojanawiwat A., et al. The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses. 2007;23:686-692 (Pubitemid 46867466)
53. Liu H., Hwangbo Y., Holte S., et al. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cellspecific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. J Infect Dis. 2004;190:1055-1058 (Pubitemid 39186790)
54. Truong L., Luong T., Scott-Algara D., et al. CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam. AIDS. 2003;17:1425-1434 (Pubitemid 36900542)
55. Saez-Cirion A., Versmisse P., Truong L., et al. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks. Retrovirology. 2006;3:81.
56. Chiu Y., Greene W. Multifaceted antiviral actions of APOBEC3 cytidine deaminases. Trends Immunol. 2006;27:291-297 (Pubitemid 43850404)
57. Vazquez-Perez J., Ormsby C., Hernandez-Juan R., Torres K., Reyes-Teran G. APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression. Retrovirology. 2009;6:23.
58. Biasin M., Piacentini L., Lo Caputo S., et al. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G:A possible role in the resistance to HIV of HIV-exposed seronegative individuals. J Infect Dis. 2007;195:960-964 (Pubitemid 46452100)
59. Speelmon E., Livingston-Rosanoff D., Li S., et al. Genetic association of the antiviral restriction factor TRIM5alpha with HIV type 1 infection. J Virol. 2006;80:2463-2471 (Pubitemid 43271552)
60. Javanbakht H., An P., Gold B., et al. Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to HIV infection. Virology. 2006;354:15-27. (Pubitemid 44468115)
61. Sewram S., Singh R., Kormuth E., et al. Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. J Infect Dis. 2009;199:1657-1663
62. Brandtzaeg P. Mucosal immunity:Induction, dissemination, and effector functions. Scand J Immunol. 2009;70:505-515
63. Van de Perre P. Transfer of antibody via mother's milk. Vaccine. 2003;21:3374-3376
64. Doria-Rose N., Klein R., Daniels M., et al. Breadth of HIV-specific neutralizing activity in sera:Clustering analysis and association with clinical variables. J Virol. 2010;84:1631-1636
65. Richman D., Wrin T., Little S., Petropoulos C. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA. 2003;100:4144-4149 (Pubitemid 36418171)
66. Lopalco L., Barassi C., Paolucci C., et al. Predictive value of anti-cell and anti-HIV humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin. J Gen Virol. 2005;86:339-348 (Pubitemid 40227945)
67. Ahearne P., Matthews T., Lyerly H., White G., Bolognesi D., Weinhold K. Cellular immune response to viral peptides in patients exposed to HIV. AIDS Res Hum Retroviruses. 1988;4:259-267
68. Clerici M., Giorgi J., Chou C., et al. Cell-mediated immune response to HIV type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis. 1992;165:1012-1019
69. Borghi M., De Santis C., Barcellini W., et al. Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patients. J Acquir Immune Defic Syndr. 1993;6:1114-1119 (Pubitemid 23293244)
70. Callahan L., Roderiquez G., Mallinson M., Norcross M. Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4. J Immunol. 1992;149:2194-2202
71. Burastero S., Gaffi D., Lopalco L., et al. Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals. AIDS Res Hum Retroviruses. 1996;12:273-280 (Pubitemid 26072302)
72. Beretta A., Weiss S., Rappocciolo G., et al. HIV-1-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope. J Infect Dis. 1996;173:472-476 (Pubitemid 26042453)
73. Lopalco L., Pastori C., Cosma A., et al. Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity. AIDS Res Hum Retroviruses. 2000;16:109-115 (Pubitemid 30060981)
74. Ditzel H., Rosenkilde M., Garred P., et al. The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals:Identification of chemokine and HIV-1-blocking human antibodies. Proc Natl Acad Sci USA. 1998;95:5241-5245 (Pubitemid 28208582)
75. Lopalco L., Barassi C., Pastori C., et al. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro. J Immunol. 2000;164:3426-3433 (Pubitemid 30149010)
76. Lopalco L., Magnani Z., Confetti C., et al. Anti-CD4 antibodies in exposed seronegative adults and in newborns of HIV type 1-seropositive mothers:A follow-up study. AIDS Res Hum Retroviruses. 1999;15:1079-1085 (Pubitemid 29379803)
77. Tenenbaum S., Morris C., Alexander S., McFerrin H., Garry R., Leissinger C. Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera. J Virol. 2005;2:65.
78. Lizeng Q., Nilsson C., Sourial S., et al. Potent neutralizing serum immunoglobulin A (IgA) in HIV type 2-exposed IgG-seronegative individuals. J Virol. 2004;78:7016-7022 (Pubitemid 38781540)
79. Nguyen M., Pean P., Lopalco L., et al. HIV-specific antibodies but not t-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia. J Acquir Immune Defic Syndr. 2006;42:412-419 (Pubitemid 44050887)
80. Farquhar C., VanCott T., Bosire R., et al. Salivary HIV-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya. Clin Exp Immunol. 2008;153:37-43. (Pubitemid 351809333)
81. Hasselrot K., Bratt G., Hirbod T., et al. Orally exposed uninfected individuals have systemic anti-HIV responses associating with partners' viral load. AIDS. 2010;24:3-43.
82. Letvin N.L., Rao S., Dang V., et al. No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J Virol. 2007;81:12368-12374 (Pubitemid 350085850)
83. Ng C., Jaworski J.P., Jayaraman P., et al. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nat Med. 2010;16:1117-1119
84. Kaul R., Plummer F., Kimani J., et al. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol. 2000;164:1602-1611 (Pubitemid 30067280)
85. Alimonti J., Kimani J., Matu L., et al. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol Cell Biol. 2006;84:482-485 (Pubitemid 44286043)
86. Skurnick J., Palumbo P., De Vico A., et al. Correlates of non-transmission in US women at high risk of HIV type 1 infection through sexual exposure. J Infect Dis. 2002;185:428-438 (Pubitemid 34142804)
87. Missale G., Papagno L., Penna A., et al. Parenteral exposure to high HIV viremia leads to virus-specific T cell priming without evidence of infection. Eur J Immunol. 2004;34:3208-3215 (Pubitemid 39549399)
88. Makedonas G., Bruneau J., Alary M., et al. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally. AIDS. 2005;19:251-259 (Pubitemid 40396556)
89. Perez C., Hasselrot K., Bratt G., Broliden K., Karlsson A. Induction of systemic HIV-1-specific cellular immune responses by oral exposure in the uninfected partner of discordant couples. AIDS. 2010;24:969-974
90. Furci L., Lopalco L., Loverro P., et al. Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals. AIDS. 2002;16:1003-1008 (Pubitemid 34499423)
91. Kaul R., Dong T., Plummer F., et al. CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest. 2001;107:1303-1310 (Pubitemid 32494547)
92. Kaul R., Rowland-Jones S., Kimani J., et al. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett. 2001;79:3-13. (Pubitemid 32938202)
93. Kebba A., Kaleebu P., Rowland S., et al. Distinct patterns of peripheral HIV-1-specific interferon-gamma responses in exposed HIV-1-seronegative individuals. J Infect Dis. 2004;189:1705-1713 (Pubitemid 38648301)
94. Erickson A., Willberg C., McMahan V., et al. Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional HIV type 1-specific CD8(+) T-cell responses which can be defined to the epitope level. Clin Vaccine Immunol. 2008;15:1745-1748
95. Fowke K., Kaul R., Rosenthal K., et al. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunol Cell Biol. 2000;78:586-595
96. Pallikkuth S., Wanchu A., Bhatnagar A., Sachdeva R., Sharma M. HIV gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India. Clin Vaccine Immunol. 2007;14: 1196-1202 (Pubitemid 47518087)
97. Suresh P., Wanchu A., Bhatnagar A., Sachdeva R., Sharma M. Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India. AIDS Res Hum Retroviruses. 2007;23:261-268 (Pubitemid 46418339)
98. Eyeson J., King D., Boaz M., et al. Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects. AIDS. 2003;17:2299-2311 (Pubitemid 38147015)
99. Restrepo C., Rallon N., Del Romero J., et al. Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals. J Immunol. 2010;185:982-989
100. Hirbod T., Kaul R., Reichard C., et al. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS. 2008; 22:727-735 (Pubitemid 351450641)
101. Kaul R., Rutherford J., Rowland-Jones S., et al. HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers:A prospective analysis. AIDS. 2004;18:2087-2089 (Pubitemid 39463364)
102. Kaul R., Rowland-Jones S., Kimani J., et al. Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Invest. 2001;107:341-349 (Pubitemid 32157966)
103. Liu Y., Woodward A., Zhu H., et al. Preinfection HIV-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners. J Virol. 2009;83:10821-10829
104. Tran H., Chartier L., Troung L., et al. Systemic immune activation in HIV- 1-exposed uninfected Vietnamese intravascular drug users. AIDS Res Hum Retroviruses. 2006;22:255-261
105. Schenal M., Lo Caputo S., Fasano F., et al. Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS. 2005;19:653-661 (Pubitemid 40593070)
106. Biasin M., Caputo S., Speciale L., et al. Mucosal and systemic immune activation is present in HIV-exposed seronegative women. J Infect Dis. 2000;182:1365-1374
107. Jennes W., Sawadogo S., Koblavi-Deme S., et al. Cellular HIV-protective factors:A comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Cote d'Ivoire. J Infect Dis. 2003;187:206-214 (Pubitemid 36132634)
108. Begaud E., Chartier L., Marechal V., et al. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology. 2006;3:35.
109. Koning F., Otto S., Hazenberg M., et al. Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol. 2005;175:6117-6122 (Pubitemid 41508099)
110. Card C., McLaren P., Wachihi C., Kimani J., Plummer F., Fowke K. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. J Infect Dis. 2009;199:1318-1322
111. Camara M., Dieye T., Seydi M., et al. Low-level CD4+ T cell activation in HIV-exposed seronegative subjects:Influence of gender and condom use. J Infect Dis. 2010;201:835-842